InsiderSignal.AI

InsiderSignal.ai

AGIO - Agios Pharmaceuticals, Inc.

Insider Sale by Burns James William (GC)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Burns James William, serving as GC at Agios Pharmaceuticals, Inc. (AGIO), sold 3,280 shares at $34.71 per share, for a total transaction value of $113,849.00. Following this transaction, Burns James William now holds 49,306 shares of AGIO.

This sale represents a 6.00% decrease in Burns James William's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 2, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 6, 2026, 4 days after the trade was made.

Agios Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Burns James William

GC

James William Burns is the Chief Legal Officer (GC) at Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a biopharmaceutical company focused on developing transformative medicines for rare diseases.[[1]](https://www.investing.com/news/insider-trading-news/agios-pharmaceuticals-chief-legal-officer-sells-114-million-in-stock-93CH-3717871)[[3]](https://www.gurufocus.com/insider/171977/james-william-burns)[[4]](https://rocketreach.co/agios-pharmaceuticals-management_b5c93439f42e3701) Based in Cambridge, MA, at the company's headquarters on 88 Sidney Street, Burns has been actively involved in insider transactions, including selling 21,752 shares for approximately $1.14 million on November 7, 2024, under a Rule 10b5-1 trading plan, and 2,799 shares for $93,878 on June 24, 2025, to cover tax obligations on vesting performance share units.[[1]](https://www.investing.com/news/insider-trading-news/agios-pharmaceuticals-chief-legal-officer-sells-114-million-in-stock-93CH-3717871)[[2]](https://www.investing.com/news/insider-trading-news/agios-pharma-chief-legal-officer-burns-sells-93k-in-stock-93CH-4113791)[[5]](https://www.otcmarkets.com/filing/html?id=19036374&guid=B0t-kKoEZUz5DYh)[[6]](https://www.sec.gov/Archives/edgar/data/1900772/000143922226000010/xslF345X03/wk-form4_1767403081.xml) Burns continues to hold shares in Agios following these transactions and is listed among key executives alongside the Chief Commercial Officer.[[3]](https://www.gurufocus.com/insider/171977/james-william-burns) While specific prior career highlights and education details are not detailed in available sources, his role as CLO underscores his expertise in legal matters for a firm advancing products like mitapivat (PYRUKYND) for sickle cell disease and thalassemia.[[1]](https://www.investing.com/news/insider-trading-news/agios-pharmaceuticals-chief-legal-officer-sells-114-million-in-stock-93CH-3717871)[[2]](https://www.investing.com/news/insider-trading-news/agios-pharma-chief-legal-officer-burns-sells-93k-in-stock-93CH-4113791)[[4]](https://rocketreach.co/agios-pharmaceuticals-management_b5c93439f42e3701)

View full insider profile →

Trade Price

$34.71

Quantity

3,280

Total Value

$113,849.00

Shares Owned

49,306

Trade Date

Thursday, April 2, 2026

7 days ago

SEC Filing Date

Monday, April 6, 2026

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Agios Pharmaceuticals, Inc.

Company Overview

No company information available
View news mentioning AGIO

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5420151

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime